Navigation Links
Precision Biomonitoring Launches TripleLockTM a Revolutionary DNA Survey Service To Improve Environmental Assessments

Precision Biomonitoring, leaders in the environmental DNA (eDNA) detection of organisms for biomonitoring surveys, launches TripleLockTM technology, a commercially available eDNA solution that provides more accurate detection of species, more rapidly, and at a lower cost in comparison to conventional methods based on visual identification of captured specimens.

In an industry when time is of the essence, environmental professionals and their clients are actively seeking accurate, quick and low-cost biomonitoring surveys of invasive, keystone and at-risk species. Precision Biomonitoring is proud to offer TripleLockTM, the latest development in biomonitoring technology, with methodology and testing that has been rigorously developed and validated. TripleLockTM environmental biomonitoring surveys allow for traces of DNA shed by organisms through bodily fluids, skin cells and other excretions, to be detected in water samples without having to directly collect organisms themselves. Field test eDNA results can be uploaded in real time, and quickly made available on a secure server to be accessed by clients anywhere, anytime.

“eDNA detection makes determination of presence or absence of target species more rapid, with less risk of errors. It also lowers the cost of surveys because less time is spent trying to capture rare endangered species. We anticipate that our breakthrough solution will complement or replace conventional methods in many types of biomonitoring surveys. With TripleLockTM, our goal is to bring to the environmental consulting industry advanced molecular surveys that will help to obtain the permits needed for their clients,” states Dr. Mario Thomas, Chief Executive Officer and Co-founder, Precision Biomonitoring. “With our novel molecular survey solution, environmental professionals can now access rigorously developed and validated DNA tests, and survey methods they can trust. And because we conduct the eDNA surveys right in the field, there is no need to ship samples to a distant lab with the risk of delays and loss of sample integrity. We’re thrilled to bring TripleLockTM to market and see how eDNA survey services will make a difference for our customers.”

More About Precision Biomonitoring:
Founded in 2016 by a team of scientists from the Biodiversity Institute at Ontario’s University of Guelph, Precision Biomonitoring serves customers across the country with eDNA testing for 30 different invasive, keystone and at-risk aquatic species.

Precision Biomonitoring develops and delivers environmental DNA gold standard tests, survey methods and data management tools to environmental consulting firms and conservation agencies across the country. These environmental DNA surveys are a vital component to any environmental decision-making process, and it is a necessity that test results be quick, accurate and reliable. The Precision Biomonitoring team is at the forefront of technological innovations in the industry, and committed to offering environmental survey and testing services that are cost-efficient for all parties.

Read the full story at

Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved

Related medicine technology :

1. Precision for Medicine Adds Regulatory Expertise To Support Next Generation Medicines
2. Quartz Bio SA Supports Debiopharm Group Precision Medicine Bioinformatics
3. World Molecular Imaging Congress to Feature Scientific Breakthroughs in Molecular Multimodal Imaging Essential to Precision Medicine
4. Technology Innovation Provides Catalyst for Scientific Breakthroughs in Precision Medicine at World Molecular Imaging Congress
5. TechPrecision Corporation Schedules Conference Call to Report Fiscal 2014 Second Quarter Financial Results
6. Philips receives FDA 510(k) Clearance for TAVI Precision Treatment Planning Application
7. Trovagene Expands Clinical Program with New Study Evaluating its Precision Cancer Monitoring Platform in Lung Cancer
8. Clinical Performance of Trovagenes Precision Cancer Monitoring Platform Presented at Second Annual International ECD Medical Symposium
9. Clinical Study Using Trovagenes Precision Cancer Monitoring Platform Published in Cancer Discovery
10. Precision for Medicine Awarded NIH Contract Valued at $28 Million
11. MEMS Gyroscopes Analog Devices ADIS16136 Precision Angular Rate Sensor Reverse Costing Analysis
Post Your Comments:
(Date:1/23/2020)... ... , ... Please join American Society of Nuclear Cardiology (ASNC) in congratulating Sharmila ... 2020. Dr. Dorbala is the director of nuclear cardiology at Brigham and Women’s Hospital, ... Over more than 20 years as an ASNC member, she has held various officer ...
(Date:1/23/2020)... ... ... Claremont Place Senior Living, a Meridian Senior Living ... deficiency-free survey in August 2019 as administered by the California Department of Public Health ... our committed and caring staff, that not only meets, but also exceeds state standards,” ...
(Date:1/22/2020)... ... 22, 2020 , ... Somatus, the market leader in providing ... groups, today announced it is expanding its renal management partnership with BlueCross BlueShield ... chronic kidney disease (CKD). This partnership previously only served BCBST’s Medicare Advantage members ...
Breaking Medicine Technology:
(Date:1/27/2020)... ... ... The National Lacrosse League (@NLL), the premier professional lacrosse league in the ... the United States. The AT&T deal is the latest in a series of announcements ... , “There are few brands that are more tied to sports business success and ...
(Date:1/25/2020)... ... ... Trust must be earned. It’s a slow, gradual, and fragile process, which ... others. Yet the motives behind a deep sense of distrust can be complex. Some ... feeling the pain of betrayal. Dig far enough into a distrusting person’s past, and ...
(Date:1/24/2020)... ... ... The new strain of Wuhan coronavirus was first identified in China in ... South Korea. The virus is believed to have started in the Chinese city of ... , EPA has confirmed that the 2019 novel coronavirus-Wuhan (also 2019-nCoV) has met the ...
(Date:1/23/2020)... ... January 23, 2020 , ... The Icahn School of Medicine ... patient care—today announced the recipients of the first-of-its-kind Distinguished Scholar Award, a new ... The awards aim to mitigate gender gaps in medical research by supporting researchers ...
(Date:1/23/2020)... ... 23, 2020 , ... Worldwide Business with kathy ireland® is pleased ... and Vice President of Dairy and Frozen, Jimmy Farber to discuss their healthy, affordable ... organic food and snack options at an affordable price. The company believes that the ...
Breaking Medicine News(10 mins):